State Street’s ENDRA Life Sciences NDRA Stock Holding History

State Street’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3	Closed	-$32K	–	4884
2022 Q3	$32K	Hold	3	–	–	﹤0.01%	4751
2022 Q2	$25K	Hold	3	–	–	﹤0.01%	4851
2022 Q1	$41K	Hold	3	–	–	﹤0.01%	4830
2021 Q4	$67K	Hold	3	–	–	﹤0.01%	4652
2021 Q3	$167K	Buy	3 +1	+50%	+$63.9K	﹤0.01%	4419
2021 Q2	$131K	Buy	+2	New	+$157K	﹤0.01%	4314

Other funds holding NDRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

State Street's NDRA Position: Q4 2022 in Review

State Street sold out of ENDRA Life Sciences (NDRA) in Q4 2022, closing a stake of 3 shares — an estimated $32K sold.

State Street first reported a position in NDRA in Q2 2021 and held it in 6 quarters. The position peaked at $167K in Q3 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q4 2022.

State Street reported no remaining ENDRA Life Sciences position as of Q4 2022 after selling out during the quarter.
State Street sold 3 ENDRA Life Sciences shares in Q4 2022, an estimated $32K.
State Street first reported a position in ENDRA Life Sciences in Q2 2021 and held it in 6 quarters.
State Street's ENDRA Life Sciences position peaked at $167K in Q3 2021.
8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.